Pembrolizumab
Merck
['pembro', 'key,note,789', 'sclc', 'key,note,62', 'nsclc']
 #asco23 negative results of #keynote789 trial: platinum + pem +/- pembro for tki-resistant #egfr mutant #nsclc pfs hr 0.8, p=0.0122
mpfs: 5.6 vs 5.5 mths os hr 0.84, p=0.0362
mos: 15.9 vs 14.7 mths after tki , adding pembro to chemo does not improve os 
Associate Professor/Thoracic Oncologist/Vice Chair-Education/#HemOnc Fellowship Director @MayoClinic FL/Assoc Editor @ASCO #Education #LungCancer الرئة #أورام